Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Medicine, Gynecology, Oncology +16

<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas

Kimberly C. Wiegand, Sohrab P. Shah, Osama M. Al‐Agha et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

Medicine, Genetics, Oncology +17

Cancer statistics, 1995

Phyllis A. Wingo, T. Tong, S. Bolden · CA A Cancer Journal for Clinicians · 1995 · 1.4K citations · Full text

Medicine, Biostatistics, Oncology +17

Frequent Mutations of Chromatin Remodeling Gene <i>ARID1A</i> in Ovarian Clear Cell Carcinoma

Siân Jones, Tian‐Li Wang, Ie‐Ming Shih et al. · Science · 2010 · 1.2K citations

Medicine, Genetics, Oncology +16

Clinical characteristics of clear cell carcinoma of the ovary

Toru Sugiyama, Toshiharu Kamura, Junzo Kigawa et al. · Cancer · 2000 · 804 citations

Medicine, Oncology, Pathology +14